4.5 Article

Impact of MCP-1 in Atherosclerosis

期刊

CURRENT PHARMACEUTICAL DESIGN
卷 20, 期 28, 页码 4580-4588

出版社

BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1381612820666140522115801

关键词

MCP-1; CCL2; CCLR2; atherosclerosis and chemokine

资金

  1. Trustees of the Thrombosis Research Institutes in London
  2. Garfield Weston Foundation, UK
  3. National Natural Science Foundation of China [31000475]

向作者/读者索取更多资源

Monocyte chemotactic protein-1 (MCP-1) (also referred to as chemokine (C-C motif) ligand 2 (CCL2) is expressed by mainly inflammatory cells and endothelial cells. The expression level is upregulated after proinflammatory stimuli and tissue injury which are associated with atherosclerotic lesion. Atherosclerosis is a progressive disease starting with accumulation of lipids, lipoproteins, and immune cells in the arterial wall. MCP-1 has been reported to play an important role in the pathogenesis of atherosclerosis and considerable evidence supports that the monocyte containing MCPs and macrophage influences the growth of other cell types within the atherosclerotic lesion. This review will focus on the general structure features of MCP-1 and its role in atherosclerosis.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据